<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01423929</url>
  </required_header>
  <id_info>
    <org_study_id>2011-001452-11</org_study_id>
    <nct_id>NCT01423929</nct_id>
  </id_info>
  <brief_title>Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion</brief_title>
  <acronym>SOCCER</acronym>
  <official_title>Supplemental Oxygen in Catheterized Coronary Emergency Reperfusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of SOCCER is to evaluate the effects of treatment with supplemental O2 before and
      during acute balloon angioplasty (PCI) for patients with ST-elevation myocardial infarction
      (STEMI). One hundred STEMI patients are randomized in the ambulance to either standard O2
      treatment (10 l/min) or no supplemental O2, to be given until the end of the acute PCI.
      Cardiac magnetic resonance imaging and echocardiography during the hospital stay is used to
      assess infarct size and myocardial performance. All patients are followed for 6 months. At 6
      months, perceived health and NT-proBNP are recorded for all patients, and an additional
      echocardiography is performed. The primary endpoint is the fraction of myocardium saved with
      the acute PCI. The secondary endpoints include the pain difference between inclusion time and
      start of PCI and myocardial performance on echocardiography.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Almost all patients with ST elevation myocardial infarction (STEMI) in Sweden undergo acute
      balloon angioplasty (PCI) to open the occluded coronary artery, and thereby to reduce or
      abolish the myocardial infarction. Standard treatment in these cases is 10-15 l of
      supplemental oxygen to reduce the myocardial ischemia and the infarct size. It is, however,
      unknown whether supplemental O2 is beneficial or detrimental to patients with STEMI
      undergoing PCI.

      This study aims to evaluate the effects of treatment with supplemental O2 in acute PCI for
      STEMI.

      The study is a multicenter single blind parallel group randomized trial. One hundred normoxic
      STEMI ambulance patients accepted for primary PCI are randomized in the ambulance to either
      standard O2 treatment (10 l/min) or no supplemental O2, to be given until the end of the
      acute PCI. All patients undergo cardiac MRI at day 4-6 to determine area at risk, infarct
      size and myocardial salvage index. Fifty patients undergo an extended echocardiography during
      the hospital stay to assess infarct size and wall motion score index. All patients are
      followed for 6 months. At 6 months, perceived health (EQ-5D) and NT-proBNP are recorded for
      all patients, and an additional echocardiography is performed for the subgroup of 50
      patients. The primary endpoint is myocardial salvage index. Secondary endpoints include pain
      difference between inclusion time and start of PCI and wall motion score index on
      echocardiography.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">February 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Myocardial salvage index</measure>
    <time_frame>Day 4-6 after the acute PCI</time_frame>
    <description>Assessed by cardiac magnetic resonance imaging</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain difference</measure>
    <time_frame>At randomization vs at PCI balloon inflation start</time_frame>
    <description>Visual analog scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area at risk</measure>
    <time_frame>Day 4-6 after the acute PCI</time_frame>
    <description>Assessed by cardiac magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infarct size</measure>
    <time_frame>Day 4-6 after the acute PCI</time_frame>
    <description>Assessed by cardiac magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ejection fraction</measure>
    <time_frame>Day 4-6 after the acute PCI</time_frame>
    <description>Assessed by cardiac magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microvascular obstruction</measure>
    <time_frame>Day 4-6 after the acute PCI</time_frame>
    <description>Assessed by cardiac magnetic resonance imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Doses of opioids (substance and mg) and betablockers (substance and mg)</measure>
    <time_frame>Given before and during the PCI</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood oxygen saturation change</measure>
    <time_frame>From inclusion to PCI start</time_frame>
    <description>Measured by pulse oximeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infarct size</measure>
    <time_frame>First 24 h after inclusion</time_frame>
    <description>Measured with area under TnT curve</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ST segment recovery</measure>
    <time_frame>90 minutes after acute PCI</time_frame>
    <description>As measured on ECG</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TIMI flow</measure>
    <time_frame>During acute PCI</time_frame>
    <description>Measured with coronary angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of heart failure medications (beta blockers, ACEI, ARB, diuretics, digoxin and sinus node inhibitors etc)</measure>
    <time_frame>At 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived health</measure>
    <time_frame>At 6 months</time_frame>
    <description>Measured with EQ-5D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wall motion score index on echocardiography</measure>
    <time_frame>Day 2-3 after acute PCI</time_frame>
    <description>Measured on echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in wall motion score index</measure>
    <time_frame>From index hospitalization to 6 months</time_frame>
    <description>Measured on echocardiography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>10 L O2/min</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oxygen breathing via Oxymask TM</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Room air</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Room air breathing via Oxymask TM</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>Fitting of Oxymask TM and treatment with 10 L O2/min</description>
    <arm_group_label>10 L O2/min</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Room air</intervention_name>
    <description>Fitting of Oxymask TM</description>
    <arm_group_label>Room air</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  STEMI patient transported with ambulance to SUS Lund or Malmö or Helsingborg hospital,
             and accepted for acute PCI

          -  Symptom duration less than 6 hours

          -  Normal SaO2 (≥ 94 %) measured with pulse oximeter

          -  Informed consent

        Exclusion Criteria:

          -  Previous AMI

          -  Inability to make decision to participate; dementia and the like

          -  For CMR: Significant claustrophobia, prostheses or other magnetic material inside the
             body
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf Ekelund, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Skåne University Hospital at Lund</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Helsingborg Hospital</name>
      <address>
        <city>Helsingborg</city>
        <zip>SE251 87</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUS Lund</name>
      <address>
        <city>Lund</city>
        <zip>SE22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUS Malmö</name>
      <address>
        <city>Malmö</city>
        <zip>SE20502</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <reference>
    <citation>Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Weatherall M, Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart. 2009 Mar;95(3):198-202. doi: 10.1136/hrt.2008.148742. Epub 2008 Aug 15. Review.</citation>
    <PMID>18708420</PMID>
  </reference>
  <reference>
    <citation>Burls A, Cabello JB, Emparanza JI, Bayliss S, Quinn T. Oxygen therapy for acute myocardial infarction: a systematic review and meta-analysis. Emerg Med J. 2011 Nov;28(11):917-23. doi: 10.1136/emj.2010.103564. Epub 2011 Feb 23. Review.</citation>
    <PMID>21346260</PMID>
  </reference>
  <reference>
    <citation>Nicholson C. A systematic review of the effectiveness of oxygen in reducing acute myocardial ischaemia. J Clin Nurs. 2004 Nov;13(8):996-1007. Review.</citation>
    <PMID>15533106</PMID>
  </reference>
  <reference>
    <citation>Beasley R, Aldington S, Weatherall M, Robinson G, McHaffie D. Oxygen therapy in myocardial infarction: an historical perspective. J R Soc Med. 2007 Mar;100(3):130-3. Review.</citation>
    <PMID>17339308</PMID>
  </reference>
  <reference>
    <citation>Farquhar H, Weatherall M, Wijesinghe M, Perrin K, Ranchord A, Simmonds M, Beasley R. Systematic review of studies of the effect of hyperoxia on coronary blood flow. Am Heart J. 2009 Sep;158(3):371-7. doi: 10.1016/j.ahj.2009.05.037. Epub 2009 Jul 15. Review.</citation>
    <PMID>19699859</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2011</study_first_submitted>
  <study_first_submitted_qc>August 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2011</study_first_posted>
  <last_update_submitted>August 30, 2016</last_update_submitted>
  <last_update_submitted_qc>August 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Oxygen</keyword>
  <keyword>Myocardial infarction</keyword>
  <keyword>Ambulance</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Cardiac magnetic resonance imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

